WAM
APYX icon

Watermark Asset Management’s Apyx Medical APYX Stock Holding History

Watermark Asset Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,000
Closed -$2K – 246
2017
Q2 		$2K Hold
1,000
– – ﹤0.01% 220
2017
Q1 		$3K Buy
+1,000
New +$3.32K ﹤0.01% 192

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
HK
Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Watermark Asset Management's APYX Position: Q3 2017 in Review

Watermark Asset Management sold out of Apyx Medical (APYX) in Q3 2017, closing a stake of 1,000 shares — an estimated $2K sold.

Watermark Asset Management first reported a position in APYX in Q1 2017 and held it in 2 quarters. The position peaked at $3K in Q1 2017. 39 funds tracked by Wall St. Rank hold APYX as of Q3 2017.

  • Watermark Asset Management reported no remaining Apyx Medical position as of Q3 2017 after selling out during the quarter.
  • Watermark Asset Management sold 1,000 Apyx Medical shares in Q3 2017, an estimated $2K.
  • Watermark Asset Management first reported a position in Apyx Medical in Q1 2017 and held it in 2 quarters.
  • Watermark Asset Management's Apyx Medical position peaked at $3K in Q1 2017.
  • 39 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2017.

Based on Watermark Asset Management's 13F filing for Q3 2017, filed 16 Oct 2017.